While many tumors harbor p53 loss-of-function mutations or deletions, others contain oncogenic gain-of-function mutations of p53, resulting in the expression of mutant p53 protein in tumors, and such tumors often exhibit poor prognosis and aggressive tumor phenotypes (Muller and Vousden, 2013). This evidence concerns the gene TP53 and neoplasm.